Temozolomide in Association With Topotecan in Refractory or Relapsed Malignant Tumors in Children and Adolescents

NCT00412503 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Refractory Tumors
Malignant Tumors

Interventions

DRUG: Topotecan, Temozolomide

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris